15th ISCT Annual Meeting

描述(由申请人提供)： ISCT年会是那些致力于或对基于细胞的治疗开发感兴趣的人与来自世界各地的学术界、工业界和监管机构的同事交流科学、临床、技术、商业和监管信息的最佳机会。去年的大会接待了来自世界各地的660多名代表。 我们预计今年还会有小幅增长，并计划接待700多人。为了加强我们的计划，我们增加了一个互动的公共会议，旨在鼓励高中生和大学生在细胞治疗领域从事研究人员和医生的职业生涯。 本次会议的主席是希望之城癌症免疫治疗和肿瘤免疫学部临床主任Steven Forman博士和斯克里普斯研究所分子和实验医学系副教授Bruce Torbett博士。 计划目标 ISCT年会的目标包括：(A)强调所有类型的细胞和组织研究的翻译方面和涉及的问题 (B)鼓励来自学术界和工业界的科学家、临床医生、实验室人员、监管专业人员以及其他人跨学科参与学会活动(例如，成员资格、出版物、教育方案、会议等) (C)处理与每类基于细胞的研究/治疗有关的科学、临床、实验室和管理问题 (D)促进将较成熟的细胞研究领域(如造血干细胞移植)的信息和经验转化到其他新兴领域，包括间充质干细胞、胰岛细胞等非造血领域；以及 (D)促进将信息和经验从资深从业人员转让给该领域的青年科学家。(摘要结束)

DESCRIPTION (provided by applicant): The ISCT annual meeting is the premier opportunity for those working or interested in cell based therapeutic development to exchange scientific, clinical, technical, commercial, and regulatory information with colleagues from academia, industry, and regulatory agencies around the world. Last year's conference welcomed over 660 delegates from all over the world. We expect a modest increase again this year and are planning to host over 700 people. To enhance our program, we are adding an interactive Public Session aimed at encouraging high school and college students to pursue careers as researchers and physicians in the area of cellular therapy. The chairs of this meeting are Dr. Steven Forman, Clinical Director, Division of Cancer Immunotherapeutics and Tumor Immunology, City of Hope and Dr. Bruce Torbett, Associate Professor, Department of Molecular and Experimental Medicine, Scripps Research Institute. Program Objectives The objectives of the ISCT annual meeting include: (a) emphasizing the translational aspects of and issues involved with all types of cell and tissue-based research (b) Encouraging cross-disciplinary participation in Society activities (e.g., membership, publications, educational programs, conferences, etc) from scientists, clinicians, laboratory personnel, regulatory professionals, and others from both academia and industry (c) Addressing the scientific, clinical, laboratory and regulatory issues related to each type of cell-based research/therapy (d) facilitating the translation of information and experience from more mature cellular research areas such as hematopoietic stem cell transplantation to other emerging areas including nonhematopoietic areas such as mesenchymal stem cells, islet cells, etc and (d) Facilitating the transfer of information and experience from senior practicioners to young scientists in the field. (End of Abstract)